These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 28767587)

  • 21. Prognostic value of angiopoietin-2 in non-small cell lung cancer patients: a meta-analysis.
    Xuan ZX; Zhang S; Yuan SJ; Wang W; Yu J
    World J Surg Oncol; 2016 Sep; 14(1):237. PubMed ID: 27589869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DUSP1 expression induced by HDAC1 inhibition mediates gefitinib sensitivity in non-small cell lung cancers.
    Lin YC; Lin YC; Shih JY; Huang WJ; Chao SW; Chang YL; Chen CC
    Clin Cancer Res; 2015 Jan; 21(2):428-38. PubMed ID: 25593344
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subcellular Localization of Maspin Correlates with Histone Deacetylase 1 Expression in Human Breast Cancer.
    Wakahara M; Sakabe T; Kubouchi Y; Hosoya K; Hirooka Y; Yurugi Y; Nosaka K; Shiomi T; Nakamura H; Umekita Y
    Anticancer Res; 2017 Sep; 37(9):5071-5077. PubMed ID: 28870936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coexpression of SALL4 with HDAC1 and/or HDAC2 is associated with underexpression of PTEN and poor prognosis in patients with hepatocellular carcinoma.
    Wang H; Kohashi K; Yoshizumi T; Okumura Y; Tanaka Y; Shimokawa M; Iwasaki T; Aishima S; Maehara Y; Oda Y
    Hum Pathol; 2017 Jun; 64():69-75. PubMed ID: 28411180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic Value of Expression of MicroRNAs in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.
    Zhan B; Lu D; Luo P; Wang B
    Clin Lab; 2016 Nov; 62(11):2203-2211. PubMed ID: 28164670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of hypoxia-inducible factor-1alpha, histone deacetylase 1, and metastasis-associated protein 1 in pancreatic carcinoma: correlation with poor prognosis with possible regulation.
    Miyake K; Yoshizumi T; Imura S; Sugimoto K; Batmunkh E; Kanemura H; Morine Y; Shimada M
    Pancreas; 2008 Apr; 36(3):e1-9. PubMed ID: 18362831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HDAC1 is indirectly involved in the epigenetic regulation of p38 MAPK that drive the lung cancer progression.
    Dong ZY; Zhou YR; Wang LX
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5980-5986. PubMed ID: 30280780
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrative data mining and meta-analysis to investigate the prognostic role of microRNA-200 family in various human malignant neoplasms: A consideration on heterogeneity.
    Yuan L; Bing Z; Yan P; Li R; Wang C; Sun X; Yang J; Shi X; Zhang Y; Yang K
    Gene; 2019 Oct; 716():144025. PubMed ID: 31394177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic role of B7-H4 in patients with non-small cell lung cancer: A meta-analysis.
    Tan Z; Shen W
    Oncotarget; 2017 Apr; 8(16):27137-27144. PubMed ID: 28404927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin-like growth factor receptor 1 (IGF1R) expression and survival in non-small cell lung cancer patients: a meta-analysis.
    Zhao S; Qiu Z; He J; Li L; Li W
    Int J Clin Exp Pathol; 2014; 7(10):6694-704. PubMed ID: 25400749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of CD44 variant exon 6 expression in non-small cell lung cancer: a meta-analysis.
    Zhao S; He JL; Qiu ZX; Chen NY; Luo Z; Chen BJ; Li WM
    Asian Pac J Cancer Prev; 2014; 15(16):6761-6. PubMed ID: 25169522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhancer of zeste homolog 2 as an independent prognostic marker for cancer: a meta-analysis.
    Chen S; Huang L; Sun K; Wu D; Li M; Li M; Zhong B; Chen M; Zhang S
    PLoS One; 2015; 10(5):e0125480. PubMed ID: 25974088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinicopathological features and prediction values of HDAC1, HDAC2, HDAC3, and HDAC11 in classical Hodgkin lymphoma.
    Huang R; Zhang X; Sophia S; Min Z; Liu X
    Anticancer Drugs; 2018 Apr; 29(4):364-370. PubMed ID: 29481474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of B7-H3 correlates with aggressive clinicopathological characteristics in non-small cell lung cancer.
    Wu S; Zhao X; Wu S; Du R; Zhu Q; Fang H; Zhang X; Zhang C; Zheng W; Yang J; Feng H
    Oncotarget; 2016 Dec; 7(49):81750-81756. PubMed ID: 27835582
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Expressions of HDAC1 and HDAC2 in prostate cancer and their clinical implications].
    Yin CK; Fu Q
    Zhonghua Nan Ke Xue; 2013 Aug; 19(8):699-703. PubMed ID: 24010203
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated matrix metalloproteinase-7 expression promotes metastasis in human lung carcinoma.
    Han JC; Li XD; Du J; Xu F; Wei YJ; Li HB; Zhang YJ
    World J Surg Oncol; 2015 Jan; 13():5. PubMed ID: 25588786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HDAC1 and HDAC2 independently predict mortality in hepatocellular carcinoma by a competing risk regression model in a Southeast Asian population.
    Ler SY; Leung CH; Khin LW; Lu GD; Salto-Tellez M; Hartman M; Iau PT; Yap CT; Hooi SC
    Oncol Rep; 2015 Nov; 34(5):2238-50. PubMed ID: 26352599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dysregulated Class I histone deacetylases are indicators of poor prognosis in multiple myeloma.
    Mithraprabhu S; Kalff A; Chow A; Khong T; Spencer A
    Epigenetics; 2014 Nov; 9(11):1511-20. PubMed ID: 25482492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. O-GlcNAcylation of histone deacetylases 1 in hepatocellular carcinoma promotes cancer progression.
    Zhu G; Tao T; Zhang D; Liu X; Qiu H; Han L; Xu Z; Xiao Y; Cheng C; Shen A
    Glycobiology; 2016 Aug; 26(8):820-833. PubMed ID: 27060025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Type-specific roles of histone deacetylase (HDAC) overexpression in ovarian carcinoma: HDAC1 enhances cell proliferation and HDAC3 stimulates cell migration with downregulation of E-cadherin.
    Hayashi A; Horiuchi A; Kikuchi N; Hayashi T; Fuseya C; Suzuki A; Konishi I; Shiozawa T
    Int J Cancer; 2010 Sep; 127(6):1332-46. PubMed ID: 20049841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.